|Previous Section||Index||Home Page|
5 Mar 2001 : Column: 107W
Ms Stuart [holding answer 8 January 2001]: I am advised by the Food Standards Agency that assessments of the implementation of BSE controls in European Union member states are the responsibility of the European Commission. Its Food and Veterinary Office (FVO) carries out inspection missions to all member states to check on the implementation and effectiveness of EU BSE control measures. An additional programme of urgent FVO missions is currently under way. Spain was visited in the week beginning 11 December 2000 and Sweden in the week beginning 29 January 2001. The reports of these missions will be published on the EU Commission website, as is normal practice. In the light of the findings, the EU Commission will consider whether any further protective measures are necessary beyond those already in place or under consideration.
Mr. Webb: To ask the Secretary of State for Health if he will estimate the number of recorded cases of TB (a) in the Avon area and (b) nationally in each of the last 10 years; and if he will make a statement. 
|Year||Avon health authority||England and Wales Total|
The relatively low levels of disease in this country compared with other countries can be maintained only through active TB control. We have taken steps to strengthen the surveillance, prevention and control of TB, including drug-resistant TB, within the United Kingdom. Current provision includes:
5 Mar 2001 : Column: 108W
Mr. Baker: To ask the Secretary of State for Health how many people (a) nationally and (b) in East Sussex who had an operation on the NHS waited longer than one year for that operation in each year since 1992. 
We are committed to reducing waiting times for out-patient appointments and in-patient treatment. We addressed this in the NHS Plan announced in July 2000 where we pledged that by the end of 2005 the maximum in-patient waiting time would be cut from 18 months now to six months, and the maximum out-patient waiting time would be cut from over six months now to three months. Provided we can recruit the extra staff, and the National Health Service makes the necessary reforms, our eventual objective is to reduce the maximum wait for any stage of treatment to three months by the end of 2008.
|East Sussex, Brighton and Hove||England|
Figures for 1992-93 are the sum of Brighton, Eastbourne and Hastings district health authorities
Hospital Episode Statistics
Mr. Stephen O'Brien: To ask the Secretary of State for Health what has been the total gross running costs to his Department of fees and disbursements paid to consultants in the last 12 months. 
5 Mar 2001 : Column: 109W
Mr. Stephen O'Brien: To ask the Secretary of State for Health what were his Department's total gross running costs for travel, including fares, subsistence, accommodation and any other expenses met from public funds but excluding all such costs for journeys and stays exclusively within the United Kingdom (a) since 1 May 1997 and (b) in the last 12 months. 
Mr. Stephen O'Brien: To ask the Secretary of State for Health what estimate he has made of the total gross running costs to his Department of the NDPBs accountable through his Department in the last 12 months. 
Ms Stuart: The Department estimates that the non-departmental public bodies will have received a total of £176.2 million for their gross running costs at the end of the current financial year 2000-01.
It is estimated that cancer services account for 6.3 per cent. (£1,479 million) of national health service hospital expenditure in England. This excludes cancer services not normally provided on an in-patient basis--for example, cancer screening, chemotherapy, radiotherapy and community palliative care services.
5 Mar 2001 : Column: 110W
£10 million per year extra has been invested directly in breast cancer services since 1997; since 1998 £10 million extra per year has been invested in colorectal cancer services; since 1999 £10 million extra per year has been invested in lung cancer services; and from 1999 £10 million extra per year has been available for waiting times. These sums are included in health authority baselines.
The NHS cancer plan set out funding for cancer services from 2001-02. Some £450 million has been hypothecated within health authority allocations for cancer and coronary heart disease, of which £255 million is specifically to support achievement of the cancer targets and milestones.
There is also £25 million within central budgets, which brings the total funding to £280 million for cancer in 2001-02 as promised. This money will be used to support developments including: the extension of the breast screening programme; the roll out of the cancer services collaborative; the introduction of primary care group/trust lead clinicians through a shared initiative with Macmillan Cancer Relief; and a package of support and training for community nurses in the principles of palliative care provision.
|Next Section||Index||Home Page|